Skip to main content
José Luis Molinuevo

José Luis Molinuevo

Scientific Director Alzheimer's Prevention Program

Alzheimer's Prevention Program

Group leader of the Clinical, Biomarker and Risk factors Research Group 

Scientific activity:

  • Principal Investigation of Alfa Study, Alfa+, Alfa Genetics, Alfa Cognition and Barcelonaβeta Dementia Prevention Research Clinic. 
  • National lead of EPAD, a European consortium for the prevention of Alzheimer's dementia. 
  • Co-lead of TRIBEKA, an international consortium to generate an open access neuroimaging platform.
  • Principal Investigator at BBRC of several clinical trials (Generation I, Generation II and AB1601). 
  • Membership in research networks, associations and international working groups: 
    • Member of the Neuroscience Steering Committee of the Biomarkers Consortium of the Foundation for the National Institutes of Health.
    • Member of the CSF Appropriate Use Criteria Workgroup.
    • Member of the National Institute on Aging and Alzheimer's Association (NIA-AA) Diagnostic Criteria.
    • Member of the European Alzheimer Disease Consortium.
    • Member of the Dementia Panel for the European Association of Neurology.
    • Member of the Alzheimer Biomarker Standarization Initiative.
    • Member of the  CIBER de Fragilidad y Envejecimiento Saludable.
  • He has provided scientific advice or has been an investigator or data monitoring board member for for Novartis, Pfizer, Eisai, Janssen-Cilag, Lundbeck, Roche, Bayer, Bristol-Myers Squibb, GE Health Care, Merz, MSD, GlaxoSmithKline, Astra-Zeneca, Avid, Lilly, Boehringer-Inghelmein, Biokit, Piramal, IBL y Fujireibio-Europe.
  • Scientific, technical and/or assessment commitees: 
    • Member of the Alzheimer’s Disease International (ADI) Executive Committee for the Medical and Scientific Panel (MSAP)
    • Scientist Panel on Dementia and cognitive disorders in EFNS (European Federation of Neurological Societies)
    • Expert reviewer for the Spanish National Agency for Evaluation and Prospective (ANEP)
    • Editor Journal of Alzheimer's disease
    • Editor Neurology Journal
    • Editorial Board Member of Alzheimer’s Research & Therapy
    • Editorial Board Member of Alzheimer's & Dementia: Translational Research & Clinical Interventions

Awards: 

  • 2010: Alzheimer's research award by the Spanish Society of Neurology. 
  • 2003: International Junior Investigator Award by the International College of Geriatric Psychoneuropharmacology.
  • 1998: Emili Letang Award (best residence and scientific research project), Hospital Clínic i Universitari de Barcelona.

Education:

  • 2001: PhD in Neurology. University of Barcelona, Spain. 
  • 1998: Residence in Neurology. University of Barcelona, Spain.
  • 1994: MD in Medicine. University of Valencia, Spain. 

Other positions

  • 2001-2016: Responsible of the Alzheimer's and Other Cognitive Units at Hospital Clínic de Barcelona and researcher at IDIBAPS. 
  • 1998-2001: Consultant Neurologist of the Movement Disease Unit at Hospital Clínic de Barcelona.
  • 1994-1998: Neurology resident at Hospital Clínic de Barcelona.